Pharmacological Treatment for Diabetic Macular Edema: A 2025 Update on Durability and Multi-Target Therapies. [PDF]
Drug Des Devel TherTao Y, Zhang Y, Xu W, Liu G, Liu H.
europepmc +1 more source
Multimodal imaging biomarkers associated with recurrence of diabetic macular edema during aflibercept treat-and-extend therapy. [PDF]
Sci RepKim K, Lee J, Choi J, Yu SY.
europepmc +1 more source
Microcystic macular edema in eyes with idiopathic epiretinal gliosis: A retrospective analysis before and after vitreomacular surgery : Short title: microcystic macular edema in idiopathic epiretinal gliosis. [PDF]
Graefes Arch Clin Exp OphthalmolVogt D +6 more
europepmc +1 more source
A comparative study on the efficacy and safety of biosimilar (Rimmyrah) and reference ranibizumab in patients with diabetic macular edema. [PDF]
Front PharmacolZhai G, Ren X, Xu B, Mi D.
europepmc +1 more source
Detection of cystoid macular edema in patients with retinitis pigmentosa based on deep learning. [PDF]
Int J Retina VitreousHosseini F +11 more
europepmc +1 more source
Long-Term Intravitreal Dexamethasone Implant Monotherapy in Naïve Patients with Diabetic Macular Edema. [PDF]
Turk J OphthalmolKarataş G +7 more
europepmc +1 more source
Development of a predictive model based on aqueous cytokines data for response to anti-VEGF therapy in diabetic macular edema. [PDF]
Eye Vis (Lond)Yang F +8 more
europepmc +1 more source
Therapeutic Outcomes of Anti-VEGF Agents Versus Corticosteroids in Diabetic Macular Edema: A Comparative Review. [PDF]
Int J Mol SciSanaka S, Yu M.
europepmc +1 more source
Anti-Vascular Endothelial Growth Factor Combined with Dexamethasone Implant Therapy for Macular Edema: A Randomized Controlled Trial. [PDF]
Drug Des Devel TherMa Y +6 more
europepmc +1 more source